Now Is The Time To Build A Position In Jupiter Neurosciences Inc (NASDAQ:JUNS)

In the latest trading session,, 0.71 million Jupiter Neurosciences Inc (NASDAQ:JUNS) shares changed hands as the company’s beta touched 0. With the company’s most recent per share price at $1.18 changing hands around $0.17 or 16.52% at last look, the market valuation stands at $38.95M. JUNS’s current price is a discount, trading about -1553.39% off its 52-week high of $19.51. The share price had its 52-week low at $0.51, which suggests the last value was 56.78% up since then. When we look at Jupiter Neurosciences Inc’s average trading volume, we note the 10-day average is 0.25 million shares, with the 3-month average coming to 311.79K.

Jupiter Neurosciences Inc (NASDAQ:JUNS) trade information

Instantly JUNS is in green as seen in intraday trades today. With action 5.08%, the performance over the past five days has been green. However, in the 30-day time frame, Jupiter Neurosciences Inc (NASDAQ:JUNS) is 43.70% up. Looking at the short shares, we see there were 0.28 million shares sold at short interest cover period of 0.47 days.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 25.26%. The 2025 estimates are for Jupiter Neurosciences Inc earnings to decrease by -212.50%.

JUNS Dividends

Jupiter Neurosciences Inc is expected to release its next quarterly earnings report on 2025-May-15.

Jupiter Neurosciences Inc (NASDAQ:JUNS)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 54.18% of Jupiter Neurosciences Inc shares while 1.17% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 2.56%.

Among Mutual Funds, the top two as of Apr 30, 2025 were iShares Trust-iShares Micro-Cap ETF and Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund . With 12.19 shares estimated at $14508.0 under it, the former controlled 0.04% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund held about 0.03% of the shares, roughly 9.69 shares worth around $11527.0.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.